Navigation Links
Drug That Stops Bleeding Could Save Lives
Date:6/14/2010

Giving TXA to trauma victims could prevent 100,000 deaths worldwide each year, study suggests

MONDAY, June 14 (HealthDay News) -- A drug commonly used to prevent excess bleeding in surgeries could keep thousands of people from bleeding to death after trauma, a new study suggests.

The drug, tranexamic acid (TXA) is cheap, widely available around the world and easily administered, experts said. It works by significantly reducing the rate at which blood clots break down, the researchers explained.

"When people have serious injuries, whether from accidents or violence, and when they have severe hemorrhage they can bleed to death. This treatment reduces the chances of bleeding to death by about a sixth, " said researcher Dr. Ian Roberts, a professor of epidemiology at the London School of Hygiene and Tropical Medicine in the U.K.

According to Roberts, each year about 600,000 people bleed to death worldwide. "So, if you could reduce that by a sixth, you've saved 100,000 lives in one year," he said.

The report, which was primarily funded by philanthropic groups and the British government, is published in the June 15 online edition of The Lancet.

For the study, Roberts and colleagues in the CRASH-2 consortium randomly assigned more than 20,000 trauma patients from 274 hospitals across 40 countries to injections of either TXA or placebo.

Among patients receiving TXA, the rate of death from any cause was cut by 10 percent compared to patients receiving placebo, the researchers found. In the TXA group, 14.5 percent of the patients died compared with 16 percent of the patients in the placebo group.

When the researchers looked at deaths from bleeding, those in the TXA group experienced a 15 percent reduction in mortality. Among patients receiving TXA, 4.9 percent died from bleeding, compared with 5.7 percent of the patients receiving placebo, they found.

Although there was some worry that TXA might lead to more heart attacks, strokes or clots in the lungs, the researchers observed no such increase among patients getting the drug.

Dr. Jerrold H. Levy, deputy chair for research at Emory University School of Medicine in Atlanta and author of an accompanying journal editorial, said that, "these data are really neat, because any therapy to reduce mortality in trauma is, I think, a major finding."

Using this drug to treat trauma patients is a completely new idea, Levy said. "I think people should consider it [TXA] following trauma on the basis of this study," he said.

Currently, TXA is not generally used in emergency rooms to treat trauma patients, but Roberts believes that this study could change that.

"It's not our job to tell doctors how to treat their patients, but this is a drug that is safe and effective in a condition where people have a high risk of death," he said.

The researchers believe that TXA could have even wider uses, such as reducing brain bleeds after brain injury. The drug could also be used to reduce postpartum bleeding, which the researchers say causes some 100,000 deaths a year worldwide.

In fact, a trial to see whether TXA can reduce postpartum bleeding has started, the team noted.

Levy however, cautioned that the results of this study apply only to TXA and do not mean that people should try similar drugs hoping for similar results.

"Everybody wants to be creative, but you have to look at the data, and they used TXA," Levy said. "You can't get creative and say 'Ah, one of the other drugs will do the same thing' -- you don't know that, and that's one of my concerns."

More information

For more information on trauma, visit the U.S. National Institute of General Medical Science.



SOURCES: Ian Roberts, M.D., professor, epidemiology, London School of Hygiene and Tropical Medicine, UK; Jerrold H. Levy, M.D., professor and deputy chair, research, Emory University School of Medicine, Atlanta; June 15, 2010, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding
2. Faulty gene stops cell antennae from transmitting
3. Cartoon Network's MOVE IT MOVEMENT TOUR Stops in Seattle Market
4. Vaccine Stops Tumor Spread in Mice
5. Anesthetic approach stops pain without affecting motor function
6. Anesthetic Approach Stops Pain Without Affecting Motor Function
7. Study finds beta blockers alone more effective for first variceal bleeding
8. Dual Therapy Best for Preventing Bleeding After Heart Procedures
9. First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
10. Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers
11. Bleeding Alert Sounded for Stroke Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug That Stops Bleeding Could Save Lives
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
Breaking Medicine Technology: